SPECT Biomarker Ctte

Project Snapshot

The SPECT Biomarker Committee seeks to develop a quantitative imaging profile for SPECT imaging.

Under consideration:

• quantifying a small structure (like the basal ganglion in the DaTscan, thyroid)
• quantifying organs, like the liver, for dosimetry as potential use cases

Meetings/Call Summaries

• SPECT Call Summaries

Profile Development

QIBA DRAFT Profile: Quantifying Dopamine Transporters with 123-Iodine Labeled Ioflupane in Neurodegenerative Disease(Short Title: QIBA DRAFT Profile: SPECT dopamine transporters) January 22, 2016

Reference Materials

• Quantification and Image Analysis Task Force presentation slides - Dr. Miyaoka January 12, 2016
• Quantification and Image Analysis Task Force presentation slides - Dr. Seibyl January 12, 2016

• I-123 DAT SCAN - Acquisition and Reconstruction Task Force presentation slides - Dr. Dewaraja January 5, 2016

• Acquisition Processes for SPECT - Drs. Dewaraja, Frey, and Iida (notes) December 8, 2015

• System Variance Model for SPECT Ioflupane - Drs. Smith and Zeintl (Siemens) November 20, 2015

• QIBA Claim Statement Types - Dr. Obuchowski November 20, 2015

• 03.20.2015 Link to papers of the group in Umeå that are collaborating with Dr. Ljungberg:
• The PI for this is Anne Larsson, PhD: http://www.ncbi.nlm.nih.gov/pubmed/?term=dat+scan+Larsson+A